Canada markets closed

AlzeCure Pharma AB (publ) (AC6.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.15000.0000 (0.00%)
At close: 09:18AM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-37,426
-37,167
-56,239
-77,781
-71,366
Depreciation & amortization
453
476
570
576
495
Change in working capital
1,872
39,748
-44,242
6,566
1,363
Other working capital
-35,101
3,057
-99,911
-70,693
-70,179
Net cash provided by operating activites
-35,101
3,057
-99,911
-70,639
-69,508
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-54
-671
Purchases of investments
-
-
0
-
-
Sales/Maturities of investments
0
7
-
-
-
Net cash used for investing activites
0
7
0
-54
-671
Net change in cash
-34,681
3,523
-16,164
-70,693
-70,065
Cash at beginning of period
53,718
25,577
41,741
112,434
182,499
Cash at end of period
19,037
29,100
25,577
41,741
112,434
Free Cash Flow
Operating Cash Flow
-35,101
3,057
-99,911
-70,639
-69,508
Capital Expenditure
-
-
-
-54
-671
Free Cash Flow
-35,101
3,057
-99,911
-70,693
-70,179